Search Results

Results 31 - 40 of 133 for stem cells. (4.04 seconds)
  • Nanotherapy reduces artery plaque in mice

    Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.

  • Single number IDs deadly cancer cells

    Stanford data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.

  • Omega-3s, fat stems cells linked

    A new finding by Stanford researchers represents a missing link between two worlds — that of dietary science, and that of molecular and cellular biology.

  • Cause of deadly neurological disease found

    A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.

  • Brain tumors integrate in neural wiring

    Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a Stanford study has found.

  • Irving Weissman honored for stem cell, cancer work

    Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.

  • Scientists boost neuron recovery in rats

    Stanford researchers blocked a molecule to help restore neurons in rats in which the flow of fresh blood to the brain was reduced. The approach could lead to new treatments for people who have suffered a stroke or cardiac arrest.

  • New ‘don’t eat me’ signal discovered

    Cancer cells are known to protect themselves using proteins that tell immune cells not to attack them. Stanford researchers have discovered a new “don’t eat me” signal, and blocking it may make cancer cells vulnerable to attack by the immune system.

  • Immune cells speed aging brains’ demise

    Stanford researchers have found intrusive immune cells in a place in the brains of humans and older mice where new nerve cells are born. The intruders appear to impair nerve cell generation.

  • Overcoming transplant rejection in mice

    If the antibody treatment is eventually found to be viable in humans, it could increase the numbers of people who benefit from hematopoietic stem transplants, Stanford researchers said.